# Milestone Pharmaceuticals Reports Narrower Q3 Loss

> Milestone Pharmaceuticals Inc. reported a narrower-than-expected Q3 2026 loss of $0.18 per share, beating analyst estimates by 18.2%.
- Title: Milestone Pharmaceuticals Reports Narrower Q3 Loss | Shortify
- Summary: Milestone Pharmaceuticals Inc. reported a narrower-than-expected Q3 2026 loss of $0.18 per share, beating analyst estimates by 18.2%.
- Keywords: earnings, milestone pharmaceuticals inc., mist, q3 2026, net loss, revenue, Alphastreet - Earnings Decoded. Market Intelligence Delivered
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/milestone-pharmaceuticals-reports-narrower-than-expected-q3-2026-loss
- Author: AlphaStreet Newsdesk
- Published: 2026-11-13T20:52:46+00:00
- Read time: 1 min
- Topics: earnings, milestone pharmaceuticals inc., mist, q3 2026, net loss, revenue
## Q3 2026 Financial Results
Milestone Pharmaceuticals Inc. reported a Q3 2026 loss of $0.18 per share, beating analyst expectations by 18.2%.
## Revenue and Net Loss Figures
The company generated $3.0M in revenue and a net loss of $25.8M for the quarter.
## Stock Performance
Shares declined 1.1% to $0.66 following the results.
## Year-Over-Year Loss Increase
The per-share loss widened to $0.18 from $0.12 in Q3 2025, a 50.0% year-over-year increase.
## Key takeaway

Milestone Pharmaceuticals Inc. reported a narrower-than-expected Q3 2026 loss of $0.18 per share, beating analyst estimates by 18.2%.